Source: International Business Times
The landmark decision introduces the first once-daily pill in a drug class that has dramatically lowered low-density lipoprotein cholesterol (LDL-C), commonly known as "bad" cholesterol. Issam Ahmed/AFP via Getty Images The U. S.
Aller á la Source
Nouvelles connexes
